Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies.

Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS).

Changes over time in hip fracture risk: greater improvements in men compared to women.

Clin Endocrinol (Oxf). 2018 Jun 09;: Authors: Smith R, Perera BK, Chan DWC
PURPOSE: The aim of this study was to determine whether there has been a change in the mean age and age-standardised incidence of minimal trauma... Lees meer